ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
October 06 2023 - 2:01PM
Business Wire
Article L233-8-II of the French Commercial
Code Article 223-16 of the General Regulations of the AMF
(French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX):
Market: Euronext Paris, Compartment C ISIN code:
FR0012616852
Date
Number of shares outstanding
Total voting rights
Total gross (1)
Total net (2)
September 30, 2023
29,057,059
29,057,059
28,775,385
(1)
The total number of gross (or
“theoretical”) voting rights is used as the basis for calculating
threshold crossings. In accordance with Article 223-11 of the AMF
General Regulations, this number is calculated on the basis of all
shares to which voting rights are attached, including those for
which voting rights have been suspended.
(2)
The total number of net (or “exercisable
at a Shareholders’ Meeting”) voting rights is calculated without
taking into account shares for which voting rights have been
suspended. It is released in order to ensure that the public is
properly informed, in accordance with the recommendation made by
the AMF on 17 July 2007.
About ABIONYX Pharma
ABIONYX Pharma is a new generation biotech company that aims to
contribute to health through innovative therapies in indications
where there is no effective or existing treatment, even the rarest
ones. Thanks to its partners in research, medicine,
biopharmaceuticals and shareholding, the company innovates on a
daily basis to propose drugs for the treatment of renal and
ophthalmological diseases, or new HDL vectors used for targeted
drug delivery.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231006911559/en/
NewCap Investor relations Louis-Victor Delouvrier Nicolas
Fossiez abionyx@newcap.eu +33 (0)1 44 71 98 53
NewCap Media relations Arthur Rouillé abionyx@newcap.eu
+33 (0)1 44 71 00 15
Abionyx Pharma (EU:ABNX)
Historical Stock Chart
From Apr 2024 to May 2024
Abionyx Pharma (EU:ABNX)
Historical Stock Chart
From May 2023 to May 2024